EUVIMEDEUVIMED entdecken
Crossref

Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway

Ji-Zhong Yin, Zhu-Qing Li, Xi-de Zhang, Zhi-Jie Wan, Hong-Ran Qin, Liu-Huan Yao, Bai-Long Li, Fu Gao, Yan-Yong Yang

European Journal of Pharmacology · 2024

DOI: 10.1016/j.ejphar.2023.176293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Ji-Zhong Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, 800, Xiangyin Road, 200433, Shanghai, China; Department of Res…. Hauptthemen laut MEDLINE: Bufanolides, Idiopathic Pulmonary Fibrosis, Transforming Growth Factor beta1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with no cure. Bufotalin (BT), an active component extracted from Venenum Bufonis, has been prescribed as a treatment for chronic inflammatory diseases. However, whether BT has antifibrotic properties has never been investigated. In this study, we report on the potential therapeutic effect and mechanism of BT on IPF. BT was shown to attenuate lung injury, inflammation, and fibrosis as well as preserve pulmonary function in bleomycin (BLM)-induced pulmonary fibrosis model. We next confirmed BT's ability to inhibit TGF-β1-induced epithelial-mesenchymal transition (EMT) and myofibroblast activation (including differentiation, proliferation, migration, and extracellular matrix production) in vitro. Furthermore, transcriptional profile analysis indicated the Wnt signaling pathway as a potential target of BT. Mechanistically, BT effectively prevented β-catenin from translocating into the nucleus to activate transcription of profibrotic genes. This was achieved by blunting TGF-β1-induced increases in phosphorylated Akt Ser437 (p-Akt S437) and phosphorylated glycogen synthase kinase (GSK)-3β Ser9 (p-GSK-3β S9), thereby reactivating GSK-3β. Additionally, the antifibrotic effects of BT were further validated in another in vivo model of radiation-induced pulmonary fibrosis. Collectively, these data demonstrated the potent antifibrotic actions of BT through inhibition of Akt/GSK-3β/β-catenin axis downstream of TGF-β1. Thus, BT could be a potential option to be further explored in IPF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BufanolidesIdiopathic Pulmonary FibrosisTransforming Growth Factor beta1AnimalsHumansMaleMiceA549 Cellsbeta CateninBleomycinEpithelial-Mesenchymal TransitionGlycogen Synthase Kinase 3 betaMice, Inbred C57BLProto-Oncogene Proteins c-aktWnt Signaling Pathway

Stichwörter der Autor:innen

BufotalinEpithelial–mesenchymal transitionExtracellular matrix depositionIdiopathic pulmonary fibrosisTGF-βWnt/β-catenin

Substanzen

beta CateninBleomycinBufanolidesbufotalinGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, 800, Xiangyin Road, 200433, Shanghai, China; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Naval Medica…
  • Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, 800, Xiangyin Road, 200433, Shanghai, China; Basic Medical Center for Pulmonary Disease, Naval Medical University, 800, Xiangyin Roa…
  • Department of Nuclear Radiation, Shanghai Pulmonary Hospital, Tongji University, 507, Zhengmin Road, 200433, Shanghai, China.

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Yin, J. Z., Li, Z. Q., Zhang, X. D., Wan, Z. J., Qin, H. R., Yao, L. H., Li, B. L., Gao, F., & Yang, Y. Y. (2024). Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2023.176293

Vancouver

Yin JZ, Li ZQ, Zhang XD, Wan ZJ, Qin HR, Yao LH, et al. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2023.176293

BibTeX
@article{Yin2024,
  author = {Yin, Ji-Zhong and Li, Zhu-Qing and Zhang, Xi-de and Wan, Zhi-Jie and Qin, Hong-Ran and Yao, Liu-Huan and Li, Bai-Long and Gao, Fu and Yang, Yan-Yong},
  title = {Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway},
  journal = {European Journal of Pharmacology},
  year = {2024},
  doi = {10.1016/j.ejphar.2023.176293}
}
Kostenlos starten →